CELEBRATING 20 YEARS OF TRANSFORMATIVE STEM CELL RESEARCH
DIVE INTO THE DIGITAL REPORT

Newsroom

Sickle Cell clinical trial patient Evie Junior
Headshot of S. Thomas Carmichael on left, headshot of Donald Kohn on right
A section of an artificial thymic organoid showing T cells (outlined in green) created from blood stem cells. | UCLA Broad Stem Cell Research Center/Cell Reports
Family photo: Christian and Alysia Padilla-Vaccaro with daughters Gigi (left), Annabella (seated) and Evangelina. Evangelina was born with a rare genetic immunodeficiency disorder, but thanks to a novel gene therapy at UCLA, her immune system was restored.
Photograph of Brenden Whittaker
At left, image shows white blood cells (red) from one of the X-CGD clinical trial participants before gene therapy. At right, after gene therapy, white blood cells from the same patient show the presence of the chemicals (blue) needed to attack and destroy bacteria and fungus.
Led by Dr. Donald Kohn and Katelyn Masiuk, the researchers engineered a “viral vector” that would turn on the FoxP3 gene only in regulatory T cells — and not in other types of cells.
Hussein El Kerdi during his 2016 procedure at UCLA. His father, Ali El Kerdi (with cell phone) looks on.
Headshot of Antoni Ribas in a lab coat